“Dexcom plans to first sell Stelo on a website through individual purchases or a cash-pay subscription model. Sayer said the company started with this avenue instead of a pharmacy to provide more control at launch and allow Dexcom to better […]
“CVS’ new CostVantage model will work with a formula based on how much CVS paid for the drug, a set markup over those costs, and a fee for pharmacy services to fill the prescription, according to a news release. Some […]
Kristen Holmes is in an enviable position for many health researchers, given the large proprietary dataset she has access to. In addition to the data streams from millions of fitness trackers, the company has a pile date-stamped and labeled event […]
“Medicare’s prescription drug benefit as-if-randomly assigns 65-year-olds a drug budget as a function of their birth month, beyond which out-of-pocket costs suddenly increase. Those facing smaller budgets consume fewer drugs and die more: 0.0164 percentage points per month (13.9%) for […]
Peter Attia is the golden boy of the longevity medicine movement. This is a relatively balanced article written by a doctor who spent some time with him recently. “The increasing obsession with longevity has inspired a backlash. Many in the […]
“Healthcare is expensive to run. We were finding that the increased labor and operating costs environment, like with reimbursement, both public and private, made it difficult (to run the business) and obvious we had to close,” Walmart spokeswoman Marilee McInnis […]
“Now interim CEO Yin Ho has an audacious plan to use the $140 million acquisition of AI startup ScienceIO to tap into its one major competitive advantage over giants like Epic: data.” ~ learn more
“At $226 billion annual revenues, Optum is the largest healthcare business in the US that no-one knows anything about. Optum by itself has revenues that are a little less than 5% of total US healthcare spending.” … and … “If […]
Coverage by Axios, and they named Nutrisense, which is cool! “Glucose monitoring tech could become even more widely used by nondiabetics after the Food and Drug Administration recently approved the first over-the-counter device.” ~ learn more
The PHTI is a new independant nonprofit that, “aims to provide independent, evidence-based assessments of emerging products, something that is currently lacking in the market.” Their first “blistering” report concluded that diabetes monitoring apps “do not deliver meaningful clinical benefits, […]